Blair Williams Todt - Mar 1, 2023 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
EVP and Chief Legal Officer
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Stock symbol
ELV
Transactions as of
Mar 1, 2023
Transactions value $
-$174,479
Form type
4
Date filed
3/3/2023, 03:25 PM
Previous filing
Jan 5, 2023
Next filing
Dec 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Tax liability -$174K -372 -4.49% $469.03 7.91K Mar 1, 2023 Direct F1
transaction ELV Common Stock Award $0 +2.13K +26.96% $0.00 10K Mar 1, 2023 Direct F2
transaction ELV Common Stock Award $0 +2.58K +25.73% $0.00 12.6K Mar 1, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELV Employee Stock Option (Right to Buy) Award $0 +8.2K $0.00 8.2K Mar 1, 2023 Common Stock 8.2K $469.03 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2 Represents restricted share units. Restrictions lapse as follows: 711 shares each on 3/1/2024, 3/1/2025 and 3/1/2026.
F3 Represents performance based restricted share units. Restrictions lapse on 12/1/2023.
F4 The option represents a right to purchase a total of 8,195 shares, and is exercisable in one installment of 2,731 and two installments of 2,732 each, beginning on 3/1/2024 which is the one-year anniversary of the option grant date.